Clofibrate
Back to searchMolecule Structure
Scientific Name
Clofibrate
Description of the Drug
Clofibrate is a fibric acid derivative used to treat hypertriglyceridemia and high cholesterol.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00636
http://www.drugbank.ca/drugs/DB00636
Brand Name(s)
Atromid, Atromid-s, Clofibrate
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Wyeth Ayerst Laboratories, Sandoz Inc, Watson Laboratories Inc, Banner Pharmacaps Inc, Usl Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Peroxisome proliferator-activated receptor alpha | SINGLE PROTEIN | AGONIST | CHEMBL239 |
Clinical Trial(s)
Unichem Links
| Atlas | clofibrate | ||
| SureChEMBL | SCHEMBL2356 | ||
| PharmGKB | PA449045 | ||
| Human Metabolome Database | HMDB0014774 | ||
| DrugBank | DB00636 | ||
| PubChem: Thomson Pharma | 14798427 | ||
| PubChem | 2796 | ||
| Mcule | MCULE-9236719628 | ||
| LINCS | LSM-2996 | ||
| Nikkaji | J3.314F | ||
| BindingDB | 50085047 | ||
| EPA CompTox Dashboard | DTXSID3020336 | ||
| DrugCentral | 694 | ||
| Brenda | 47220 | 1278 | 47223 |
| ChemicalBook | CB5774380 | ||
| Guide to Pharmacology | 2667 | ||
| rxnorm | CLOFIBRATE | ||
| PubChem: Drugs of the Future | 22395216 | ||
| KEGG Ligand | C06916 | ||
| ChEBI | 3750 | ||
| ZINC | ZINC000000056648 |
